- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03812484
An Evaluation of the NJSPB SCF Project for Opioid-Involved High-Risk Parolees
January 29, 2021 updated by: Clarissa Manning, Botec Analysis, LLC
An Evaluation of the New Jersey State Parole Board Swift, Certain, and Fair Project for Opioid-Involved High-Risk Parolees
This study entails an evaluation of the New Jersey State Parole Board Swift, Certain, and Fair (SCF) Supervision Program.
The purpose of the evaluation is to test whether subjects assigned to SCF Supervision perform better than those assigned to parole-as-usual (PAU).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The Swift, Certain, and Fair (SCF) Supervision Program - Including Project HOPE Program provides funding to states, units of local government, territories, and federally recognized Indian tribes (as determined by the Secretary of the Interior) in an effort to enhance public safety, foster collaboration, and to improve the outcomes of individuals under the supervision of community corrections.
The goals of this program are to develop and enhance SCF initiatives and implement the SCF model with fidelity, resulting in reduced recidivism and better outcomes for program participants.
SCF approaches are intended to: (a) improve supervision strategies that reduce recidivism; (b) promote and increase collaboration among agencies and officials who work in community corrections and related fields to enhance swift and certain sanctions; (c) enhance the offenders' perception that the supervision decisions are fair, consistently applied, and consequences are transparent; and (d) improve the outcomes of individuals participating in these initiatives.
The grantee will use awarded grant funds to support programming that provides services to up to 75 opioid involved parolees with services to divert them from a return to prison and manage underlying addictions with a combination of behavioral therapy and medication assisted treatments.
The program combines sanctions with targeted reentry and treatment services.
Study Type
Interventional
Enrollment (Actual)
77
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Toms River, New Jersey, United States, 08753
- New Jersey Reentry Corporation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants must be 18 years of age or older
- Participants must have a history of opioid use or addiction
- Participants have a history of parole violations or active parolees who are at risk for violation (this can include anyone who is reentering the active population from prison)
- Participants reside in or are moving to Ocean County; and
- Participants must have at least 6 months remaining on their Parole term
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SCF Parole
Parolee supervised under the SCF Supervision model
|
SCF Supervision entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail).
SCF Supervision includes regular random drug testing.
|
|
Active Comparator: Parole-As-Usual
Parolees are supervised under standard parole supervision practice in New Jersey.
|
Parolees are supervised under standard parole supervision practice in New Jersey
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Revocation Rate
Time Frame: 12 months
|
Percentage of subjects in each condition who are revoked from parole and returned to prison
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days Incarcerated
Time Frame: 12 months
|
Total number of days incarcerated in jail or prison
|
12 months
|
|
New Charges
Time Frame: 12 months
|
Number of new charges
|
12 months
|
|
Percent Positive Drug Tests
Time Frame: 12 months
|
Percentage of random and scheduled drug tests that test positive for illicit drugs
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Clarissa Manning, MPP, Botec Analysis, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2019
Primary Completion (Actual)
December 31, 2020
Study Completion (Anticipated)
March 31, 2021
Study Registration Dates
First Submitted
January 17, 2019
First Submitted That Met QC Criteria
January 18, 2019
First Posted (Actual)
January 23, 2019
Study Record Updates
Last Update Posted (Actual)
February 2, 2021
Last Update Submitted That Met QC Criteria
January 29, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CC100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Abuse
-
The Morton Center, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Dependence | Cannabis Dependence | Alcohol Abuse | Cannabis Abuse | Other Substance AbuseUnited States
-
Michael E. DeBakey VA Medical CenterUnknownAlcohol Dependence | Alcohol Abuse | Substance Abuse ProblemUnited States
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Prescription Drug Abuse (Not Dependent)
-
University of California, IrvineUS Department of Veterans AffairsWithdrawn
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse DisorderUnited States
-
National Institute on Drug Abuse (NIDA)CompletedSubstance Abuse DetectionUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedChild Abuse | Parent-Child Relations | Parenting | Parents | Addiction | Child Neglect | Substance Abuse Drug Chronic | Child Neglect Emotional | Parent-Child Problem | Parent / Child Problem | Parenteral Drug AbuseUnited States
-
National Institute on Drug Abuse (NIDA)CompletedDrug/Substance Abuse/Addiction | Alcohol Abuse/AddictionUnited States
-
Hammad MursaleenCompleted
Clinical Trials on SCF Supervision
-
Botec Analysis, LLCPennsylvania Department of Corrections; Bureau of Justice AssistanceUnknownSubstance Abuse | Criminal Behavior
-
Purdue UniversityTate and Lyle Ingredients Americas LLCCompletedOsteoporosisUnited States
-
Chang Gung Memorial HospitalCompleted
-
Goethe UniversityCentral Institute of Mental Health, MannheimCompleted
-
University Health Network, TorontoThe Michener Institute for Education at UHNRecruitingKeratosis | Foot Dermatoses | Forefoot Callus | PodiatryCanada
-
Purdue UniversityTate & Lyle Health & Nutrition SciencesCompletedOsteoporosis, Postmenopausal
-
Oregon Research InstituteCompletedSubstance Abuse | Delinquency | Self Destructive BehaviorUnited States
-
Diakonhjemmet HospitalRecruitingExercise | SpondyloarthritisNorway
-
Nanfang Hospital of Southern Medical UniversityGuangzhou First People's Hospital; Second Affiliated Hospital, Sun Yat-Sen... and other collaboratorsUnknownAcute Myeloid Leukemia | Minimal Residual Disease | Granulocyte Colony-stimulating FactorChina
-
University of PotsdamSwiss Council for Accident Prevention; Prof. Dr. Reto W. Kressig and Dr. Yves...CompletedFall Prevention | Fall Risk FactorsGermany